CLOSE X

HALEOS LABS LTD.

NSE : HALEOSLABSBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE1299.000 (0 %)
PREV CLOSE ( ) 1299.00
OPEN PRICE ( ) 1299.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1
TODAY'S LOW / HIGH ( )1299.00 1299.00
52 WK LOW / HIGH ( )1050.05 1680
NSE1279.30-8.4 (-0.65 %)
PREV CLOSE( ) 1287.70
OPEN PRICE ( ) 1257.70
BID PRICE (QTY) 1265.50 (4)
OFFER PRICE (QTY) 1285.30 (4)
VOLUME 858
TODAY'S LOW / HIGH( ) 1239.90 1280.00
52 WK LOW / HIGH ( )1029.05 1680
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-05 2006
Management Info
- Chairman TVVSN Murthy - Managing Director
Registered Office

Address Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040-66288888

Email info@haleoslabs.com/cs@haleoslabs.com

Website www.haleoslabs.com

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE
NEWS
30Mar Haleos Labs informs about trading wind
Haleos Labs has informed that the company has initiated the process of ‘..
09Mar Haleos Labs informs about disclosure
Haleos Labs has informed that the exchange has received the disclosure u..
21Jan Haleos Labs enters into strategic Deve
Haleos Labs has entered into strategic Development collaboration with HR..
21Jan Haleos Labs informs about collaboratio
Haleos Labs has informed that the Company has entered into strategic Dev..
10Nov SMS Lifesciences India informs about o
SMS Lifesciences India has informed that the Board of Directors of the C..
Financials
in Crores
QTR Dec 25 ANNUAL 25
Net Profit5.4121.37
Gross Profit 7.49 30.04
Operating Profit 11.6448.18
Net Sales 80.72333.37
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  13169.30 (5.91%)
M.Cap ( in Cr)16769.18
Acutaas Chemicals (BSE)
up  2225.10 (5.41%)
M.Cap ( in Cr)18134.45
Mercury Laboratories (BSE)
up  800.00 (10.96%)
M.Cap ( in Cr)96.00
Sanofi Cons. Health (BSE)
up  4647.20 (1.70%)
M.Cap ( in Cr)10686.21
Sanofi India (BSE)
up  3340.40 (2.31%)
M.Cap ( in Cr)7717.56
Shareholding Pattern
PROMOTERS 71.8%
NON-INSTITUTION 27.91%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.